Global Preliminary Screening Tests Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 2.80 Billion |
 Market Size (Forecast Year) |
USD 9.18 Billion |
 CAGR |
% |
| Major Markets Players |
|
全球初步筛查测试市场，按产品（非处方 (OTC) 快速测试产品、专业快速测试产品）、应用（传染病、心脏病学、肿瘤学、怀孕和生育、毒理学、血糖监测、其他）、最终用户（医院和诊所、诊断实验室、家庭护理、其他）– 行业趋势和预测到 2030 年。
初步筛选测试市场分析和规模
根据世界卫生组织 (WHO) 的研究，季节性流感每年在全球导致约 300 万至 500 万例重症病例。主要市场参与者越来越多地采用新型流感诊断技术并推出创新的快速流感检测，为 2023-2030 年预测期内的市场增长创造了丰厚的机会。
Data Bridge Market Research 分析，初步筛查测试市场在 2022 年为 28 亿美元，预计到 2030 年将达到 91.8 亿美元，在 2023 年至 2030 年的预测期内复合年增长率为 16%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
初步筛选测试市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
产品（非处方 (OTC) 快速检测产品、专业快速检测产品）、应用（传染病、心脏病学、肿瘤学、妊娠和生育、毒理学、血糖监测、其他）、最终用户（医院和诊所、诊断实验室、家庭护理、其他） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
Akers Biosciences, Inc. (U.S.), Abbott (U.S.), BD (U.S.), Bio-rad Laboratories, Inc. (U.S.), Cepheid (U.S.), Hologic Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), OraSure Technologies, Inc. (U.S.), Quidel Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), BUREAU VERITAS (U.S.), Eurofins Scientific (Luxembourg), Siemens Healthcare Private Limited (Germany), Luminex Corporation (U.S.), PerkinElmer Inc. (U.S.), QIAGEN (Germany), Mesa Biotech (U.S.), Illumina, Inc (U.S.) |
|
Market Opportunities |
|
Market Definition
A preliminary screening is a breath or saliva test administered by a law enforcement officer to determine whether an arrest should be made and whether an evidentiary test should be requested. Preliminary screening results may not be used as evidence of impairment in any court proceeding.
Global Preliminary Screening Tests Market Dynamics
Drivers
- Surging volume of patients suffering from various disorders
The rising number of patients suffering from cardiovascular disorders and other diseases, the increasing benefits of rapid testing over laboratory testing, the increasing number of initiatives by the government and private organisations aimed at the growth of the healthcare sector, rising levels of health expenditure globally, and favourable government policies are some of the impactful factors that are likely to accelerate the growth of the preliminary screening tests market.
On the other hand, an increasing number of applications from emerging economies, as well as the stability of the test at high temperatures and the shorter time required to initiate the test, will create new and abundant opportunities, leading to the growth of the preliminary screening tests market in the forecast period.
- Rise in prevalence of influenza
The global market is anticipated to grow as influenza prevalence rises. The centres for disease control and prevention (CDC) predicts that influenza causes somewhere between 12,000 and 79,000 fatalities annually in the United States. The market is also anticipated to develop throughout the forecast period as awareness of the value of early identification and prevention of diseases like influenza increases.
Opportunities
- Increase in the number of research and development activities
It is anticipated that increasing R&D spending will boost the global adoption rates of these diagnostic tests by providing technologically sophisticated solutions to identify influenza. The widespread use of quick diagnostic testing and the rising influenza prevalence will drive the market revenue for these tests in the upcoming years.
Restraints/Challenges
- High cost of the test
The high cost of the test, as well as its limited availability in developing economies and a lack of trained personnel, will likely limit the growth of the preliminary screening tests market during the forecast period. Stringent regulatory standards for test approval, combined with technical failure, will be the market's most significant and immediate challenge.
This preliminary screening tests market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the preliminary screening tests market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Preliminary Screening Tests Market Scope
The preliminary screening tests market is segmented on the basis of product, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Over-the-Counter (OTC) Rapid Test Product
- Professional Rapid Test Product
Application
- Infectious Disease
- HPV
- Hepatitis
- Influenza
- Malaria
- HIV
- Others
- Cardiology
- Oncology
- Pregnancy and Fertility
- Toxicology
- Glucose Monitoring
- Others
End User
- Hospital and Clinic
- Diagnostic Laboratory
- Home Care
- Others
Preliminary Screening Tests Market Regional Analysis/Insights
The preliminary screening tests market is analyzed and market size insights and trends are provided by country, product, application, and end user as referenced above.
The countries covered in the preliminary screening tests market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the preliminary screening tests market due to the growth of the healthcare sector along with availability of quick and fast service during the time of emergency.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the high occurrences of infectious diseases along with development of healthcare infrastructure.
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
初步筛查测试市场还为您提供每个国家/地区资本设备医疗保健支出增长、初步筛查测试市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对初步筛查测试市场的影响的详细市场分析。数据涵盖 2011-2021 年的历史时期。
竞争格局和初步筛选测试市场份额分析
初步筛选测试市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对初步筛选测试市场的关注有关。
初步筛选测试市场的一些主要参与者包括：
- Akers Biosciences, Inc.（美国）
- 雅培（美国）
- BD（美国）
- Bio-rad Laboratories, Inc.（美国）
- 造父变星（美国）
- Hologic Inc.（美国）
- Meridian Bioscience, Inc.（美国）
- OraSure Technologies, Inc.（美国）
- Quidel Corporation（美国）
- F. Hoffmann-La Roche Ltd（瑞士）
- 必维国际检验集团（美国）
- Eurofins Scientific（卢森堡）
- 西门子医疗私人有限公司（德国）
- Luminex 公司（美国）
- PerkinElmer Inc.（美国）
- QIAGEN（德国）
- Mesa Biotech（美国）
- Illumina 公司（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
